Status: Recruiting
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
The Use of Two YUTIQ versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment (TYNI Trial)
Participants needed: 30
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Texas Retina AssociatesUpdated: Aug 11, 2025Locations: 1
Eligibility criteria
Male or non-pregnant female in good general health at least 18 years of age, und... [+6]
Subjects with known hypersensitivity to any components of YUTIQ. [+13]